Profil
Kara J.
Stancell is currently the VP-Investor Relations & Corporate Communications at Clarus Therapeutics Holdings, Inc. She previously worked as the Executive Director-Investor Relations at Medicis Pharmaceutical Corp.
from 2010 to 2011 and as the VP-Investor Relations & Corporate Communications at Dermavant Sciences, Inc. from 2018 to 2021.
Aktive Positionen von Kara Stancell
| Unternehmen | Position | Beginn |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Kara Stancell
| Unternehmen | Position | Ende |
|---|---|---|
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Investor Relations Contact | 01.03.2021 |
| MEDICIS PHARMACEUTICAL CORP | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
